Corrigendum to “Bespoke doxorubicin-loaded gold nanoparticles for ultrasound-guided cancer cell killing” [Biomed. Pharmacother. 193 (2025) 118777] - 31/03/26

Federica Foglietta ^a, Agnese Fragassi ^b, Cristiano Pesce ^b, Francisco Andres Soto Arratia ^a, Alberto Mangia ^c, Maurizio Giustetto ^d, Gianni Durando ^e, Gian Matteo Morano ^f, Paolo Caliceti ^b, Andrea Grandoni ^g, Roberto Canaparo ^{a, ⁎} , Loredana Serpe ^a, 1

  Loredana Serpe and Stefano Salmaso equally contributed to this study

, Stefano Salmaso ^b, 1

  Loredana Serpe and Stefano Salmaso equally contributed to this study

^a Department of Drug Science and Technology, University of Torino, Torino, Italy 

^b Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Padova, Italy 

^c Department of Molecular Biotechnology and Health Sciences, Molecular Biotechnology Center, University of Turin, Turin 10126, Italy 

^d Department of Neuroscience, University of Turin, Turin 10126, Italy 

^e National Institute of Metrological Research (INRIM), Torino, Italy 

^f Esaote SpA, Genova, Italy 

^g Esaote SpA, Firenze, Italy 

^⁎ Corresponding author.

Le texte complet de cet article est disponible en PDF.